Microvascular Changes after Epiretinal Membrane Vitrectomy with Intraoperative Intravitreal Dexamethasone Implant: An OCT Angiography Analysis

被引:1
作者
Baldascino, Antonio [1 ,2 ]
Carla, Matteo Mario [1 ,2 ]
Vielmo, Lorenzo [1 ,2 ]
Gambini, Gloria [1 ,2 ]
Marzano, Francesca Carolina [3 ]
Margollicci, Fabio [1 ,2 ]
D'Onofrio, Nicola Claudio [1 ,2 ]
Rizzo, Stanislao [1 ,2 ]
机构
[1] Fdn Policlin Univ A Gemelli, Ophthalmol Dept, IRCCS, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Ophthalmol Unit, I-00168 Rome, Italy
[3] Univ Cattolica Sacro Cuore, Fac Med & Surg, I-00168 Rome, Italy
关键词
epiretinal membrane; optical coherence tomography angiography; inflammation; intravitreal dexamethasone; Ozurdex; retinal plexi; OPTICAL COHERENCE TOMOGRAPHY; DIABETIC MACULAR EDEMA; VITREORETINAL INTERFACE ABNORMALITIES; VESSEL DENSITY;
D O I
10.3390/diagnostics14040411
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We aimed to explore microvascular changes evaluated with optical coherence tomography angiography (OCTA) in patients undergoing epiretinal membrane (ERM) pars-plana vitrectomy (PPV) combined with intravitreal Ozurdex implantation, compared with standard PPV. (2) Methods: Prospective interventional analysis on 25 eyes undergoing PPV + Ozurdex (Group A) and 25 eyes undergoing PPV alone. Best corrected visual acuity (BCVA) and OCTA parameters, such as vessel density (VD) of the superficial and deep capillary plexi (SCP and DCP) in the whole 6.4 mm x 6.4 mm and fovea area, were evaluated preoperatively and 3 months after surgery. (3) Results: Postoperative BCVA significantly improved in both groups. No cases of post-operative cystoid macular edema (CME) were reported in Group A vs. two eyes in Group B. In Group A we found a statistically significant increase of SCP's VD in either the whole image (from 42.1 +/- 4.1 to 45.6 +/- 4.3%, p = 0.01) and the fovea image (from 38.5 +/- 7.5 to 41.7 +/- 4.2%, p = 0.03). In Group B, we reported no significant variations in the SCP's VDs. In the DCP, VD significantly increased only in the whole image in Group A. Stage 4 ERMs showed the greatest improvement in VD, especially in Group A. (4) Conclusions: Intraoperative Ozurdex prompted a significant BCVA recovery and limited the occurrence of postoperative CME compared to the standard procedure. Moreover, Ozurdex implant is associated with a better restoration of microvascular structure in SCP and DCP.
引用
收藏
页数:12
相关论文
共 37 条
  • [1] The Role of OCT Angiography in the Assessment of Epiretinal Macular Membrane
    Bacherini, Daniela
    Dragotto, Francesco
    Caporossi, Tomaso
    Lenzetti, Chiara
    Finocchio, Lucia
    Savastano, Alfonso
    Savastano, Maria Cristina
    Barca, Francesco
    Dragotto, Martina
    Vannozzi, Lorenzo
    Nasini, Francesco
    Faraldi, Francesco
    Rizzo, Stanislao
    Virgili, Gianni
    Giansanti, Fabrizio
    [J]. JOURNAL OF OPHTHALMOLOGY, 2021, 2021
  • [2] EN-FACE OPTICAL COHERENCE TOMOGRAPHY IN PATIENTS WITH EPIRETINAL MEMBRANE Intuitive Method for Predicting Functional Outcomes
    Bae, Kunho
    Choi, Jae Hwan
    Kim, Kyung Tae
    Kang, Se Woong
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (10): : 1972 - 1979
  • [3] Effectiveness and safety of dexamethasone implants for postsurgical macular oedema including Irvine-Gass syndrome: the EPISODIC-2 study
    Bellocq, David
    Pierre-Kahn, Vincent
    Matonti, Frederic
    Burillon, Carole
    Voirin, Nicolas
    Dot, Corinne
    Akesbi, Jad
    Milazzo, Solange
    Baillif, Stephanie
    Soler, Vincent
    Wolff, Benjamin
    Scemama, Claire
    Malcles, Ariane
    Weber, Michel
    Kodjikian, Laurent
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2017, 101 (03) : 333 - 341
  • [4] Widening use of dexamethasone implant for the treatment of macular edema
    Bonfiglio, Vincenza
    Reibaldi, Michele
    Fallico, Matteo
    Russo, Andrea
    Pizzo, Alessandra
    Fichera, Stefano
    Rapisarda, Carlo
    Macchi, Iacopo
    Avitabile, Teresio
    Longo, Antonio
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2359 - 2372
  • [5] Intravitreal dexamethasone implant for cystoid macular edema and inflammation after scleral buckling
    Bonfiglio, Vincenza
    Fallico, Matteo R.
    Russo, Andrea
    De Grande, Vittorio
    Longo, Antonio
    Uva, Maurizio G.
    Reibaldi, Michele
    Avitabile, Teresio
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2015, 25 (05) : E98 - E100
  • [6] DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTS
    Boyer, David S.
    Faber, David
    Gupta, Sunil
    Patel, Sunil S.
    Tabandeh, Homayoun
    Li, Xiao-Yan
    Liu, Charlie C.
    Lou, Jean
    Whitcup, Scott M.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (05): : 915 - 923
  • [7] Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies
    Bucolo, Claudio
    Gozzo, Lucia
    Longo, Laura
    Mansueto, Silvana
    Vitale, Daniela Cristina
    Drago, Filippo
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2018, 138 (04) : 219 - 232
  • [8] Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated With Ozurdex Trial
    Campochiaro, Peter A.
    Hafiz, Gulnar
    Mir, Tahreem A.
    Scott, Adrienne W.
    Zimmer-Galler, Ingrid
    Shah, Syed M.
    Wenick, Adam S.
    Brady, Christopher J.
    Han, Ian
    He, Lingmin
    Channa, Roomasa
    Poon, David
    Meyerle, Catherine
    Aronow, Mary Beth
    Sodhi, Akrit
    Handa, James T.
    Kherani, Saleema
    Han, Yong
    Sophie, Raafay
    Wang, Guohua
    Qian, Jiang
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 168 : 13 - 23
  • [9] Optical Coherence Tomography Angiographic Evaluation of Macular Vessel Density in Diabetic Macular Edema After Intravitreal Dexamethasone Implants: A Prospective Interventional Trial
    Capelanes, Nelson C.
    Malerbi, Fernando K.
    Novais, Eduardo A.
    Regatieri, Caio Vinicius S.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2023, 54 (03) : 174 - 182
  • [10] Do Diana V, 2006, Trans Am Ophthalmol Soc, V104, P161